Double blind comparative randomized study to evaluate efficacy and safety of CP-010, Homeopathy drug as compare to Magnesium Phosphoricum in the management of sub-acute and chronic painful conditions.â?? - Nil

Homeopathy India Private Limited0 sites116 target enrollmentTBD

ConditionsHealth Condition 1: R52- Pain, unspecifiedHealth Condition 2: null- sub-acute and chronic pain

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: R52- Pain, unspecifiedHealth Condition 2: null- sub-acute and chronic pain
Sponsor: Homeopathy India Private Limited
Enrollment: 116
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Investigators

Sponsor

Homeopathy India Private Limited

Eligibility Criteria

Inclusion Criteria

•Patients with moderate to severe pain at baseline (NRS 4 \- 10\) (Indicating the intensity of pain.),Any Sub\-acute and chronic painful condition.Patients who continue to have significant pain in spite of any form of pain killer medication. Such patients should be able to manage without increasing the dose of current pain\-killers or changing to another pain\-killer medicine, during the course of study. Patient has been informed about the study and has given her/his written informed consent.Patient understands the investigational nature of the extension study and is willing and willing to comply with trial protocol. Patients having any sub\-acute or chronic pain.

Exclusion Criteria

•Patients with severe pain due to critical conditions such as chronic abdominal conditions such as appendicitis, cholicytisis, pancreatitis, renal colic, acute rheumatoid arthritis, severe psoriatic arthritis, septic arthritis, etc.Pregnant and lactating women,Mentally retarded patients,Patients with severe or incapacitating baseline pain.Participation in a clinical trial with an investigational agent during the past 30 days or Simultaneous participation in a clinical study, Severe uncontrolled systemic disease such as diabetes, hypertension.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 4

To compare the efficacy and safety of the combined application of topical diltiazem and lignocaine gel as compared to either drugs alone in the management of anal fissuresHealth Condition 1: null- Patients of Chronic Anal Fissures

CTRI/2008/091/000280Troikaa Pharmaceuticals Limited75

Not yet recruiting

Phase 4

comparing the benefit of tablet PREGABALIN with tablet DULOXETINE and only tablet PREGABALIN in nerve pain in diabetes and relation with PPARG and Akt gene

CTRI/2021/02/031068IVERSITY COLLEGE OF MEDICAL SCIENCES

Completed

Not Applicable

A Comparative study to decrease incidence of pain on injection of propofol using newer preparations of propofol emulsion.Health Condition 1: null- children aged 6-12years under ASA 1 and 2 undergoing any elective surgical procedure under general anaesthesia

CTRI/2018/01/011562Vijayanagar Institute of Medical Sciences Ballari100

Completed

Not Applicable

Comparative study of various analgesic methods in Pediatric cardiac surgery

CTRI/2019/02/017575vrajesh kumar kodali

Terminated

Phase 3

Is ketamine a useful addition for the management of acute pain in patients where opiates alone have failed to provide adequate analgesia?

ACTRN12615001151527Bundaberg Base Hospital23